Allogene Therapeutics Inc (ALLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 96,041 | 84,514 | 173,314 | 190,021 | 223,503 |
| Marketable Securities | 394,451 | 364,536 | 283,988 | 293,464 | 364,204 |
| TOTAL | $513,028 | $469,744 | $471,323 | $502,858 | $602,171 |
| Non-Current Assets | |||||
| PPE Net | 117,216 | 120,200 | 122,990 | 125,883 | 125,459 |
| Investments And Advances | 211,333 | 298,297 | 382,378 | 396,132 | 344,342 |
| Other Non-Current Assets | 106,067 | 76,391 | 74,137 | 54,373 | 54,752 |
| TOTAL | $434,616 | $494,888 | $579,505 | $576,388 | $524,553 |
| Total Assets | $947,644 | $964,632 | $1,050,828 | $1,079,246 | $1,126,724 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,713 | 8,708 | 10,255 | 11,499 | 11,005 |
| Accrued Expenses | 34,360 | 27,763 | 37,496 | 41,626 | 34,688 |
| TOTAL | $44,909 | $36,877 | $47,907 | $53,490 | $45,998 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 836 | 406 | 156 | 365 | 305 |
| Other Non-Current Liabilities | 100,786 | 72,525 | 77,721 | 55,814 | 56,914 |
| TOTAL | $100,786 | $72,525 | $77,721 | $55,814 | $56,914 |
| Total Liabilities | $145,695 | $109,402 | $125,628 | $109,304 | $102,912 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 143,807 | 143,600 | 142,752 | 142,516 | 142,183 |
| Common Shares | 144 | 143 | 142 | 142 | 142 |
| Retained earnings | -1,057,985 | -983,198 | -894,554 | -828,480 | -750,294 |
| Other shareholders' equity | -11,472 | -9,249 | -2,567 | -398 | -334 |
| TOTAL | $801,949 | $855,230 | $925,200 | $969,942 | $1,023,812 |
| Total Liabilities And Equity | $947,644 | $964,632 | $1,050,828 | $1,079,246 | $1,126,724 |